Enterokinase: the "starting key" in the human digestive system

Enterokinase: the "starting key" in the human digestive system

Enterokinase (EK) is a serine protease present in the duodenum of mammals, which plays an indispensable role in the human digestive process. This enzyme was first discovered in 1899, and Kunitz confirmed it as a physiological activator of trypsinogen in 1939. Its unique functions and broad application prospects have attracted much attention in the fields of medicine and biotechnology.

1. Structure and function of enterokinase

Enterokinase is a heterodimeric protease consisting of a 115 kDa heavy chain (structural subunit) and a 35 kDa light chain (catalytic subunit), which are connected by a disulfide bond. The heavy chain is responsible for fixing the catalytic subunit on the brush border membrane of the small intestine, while the light chain has the function of specifically recognizing and cutting peptide bonds. Enterokinase can specifically recognize and cut a specific sequence (Asp-Asp-Asp-Asp-Lys) in trypsinogen, converting it into active trypsin, thereby initiating the activation cascade reaction of other zymogens in the digestive system.

2. The importance of enterokinase in the digestive system

Enterokinase plays the role of a "starting key" in the digestive system. It activates trypsinogen, allowing trypsin to further hydrolyze proteins and provide a basis for the body to absorb nutrients. If the human body lacks enterokinase, trypsinogen will not be activated, which will lead to symptoms such as indigestion, diarrhea, vomiting, edema, and may even lead to dysplasia, hypoproteinemia and anemia.

3. Application of enterokinase in biomedicine

In addition to its important role in the digestive system, enterokinase is also widely used in biomedicine and biotechnology. Due to its high specificity, enterokinase is widely used in the cutting and purification of genetically engineered fusion proteins. In the production process of recombinant proteins, enterokinase can accurately remove the tag part in the fusion protein and retain the integrity and function of the target protein. This characteristic makes enterokinase an indispensable tool enzyme in biopharmaceuticals.

4. The development of recombinant enterokinase

The source of natural enterokinase is limited, the extraction cost is high, and it is easily contaminated by other proteases. Therefore, genetically engineered recombinant enterokinase (rEK) came into being. Recombinant enterokinase is produced by genetic engineering technology, has higher purity and activity, and avoids the limitations of natural enterokinase. Recombinant enterokinase maintains activity over a wide range of pH values ​​(4.5-9.5) and temperatures (4-45°C), and is suitable for a variety of experimental conditions.

5. Future prospects for enterokinase

With the continuous development of biotechnology, the application prospects of enterokinase will be broader. Recombinant enterokinase not only plays an important role in biopharmaceuticals and genetic engineering, but also shows potential application value in the food industry and medical diagnosis. In the future, scientists will continue to explore more functions and applications of enterokinase and contribute to the development of human health and biotechnology.

Although the content of enterokinase in the human body is tiny, its function is crucial. It is not only a key initiator of the digestive system, but also plays an irreplaceable role in the biomedical field. Through genetic engineering technology, the application of recombinant enterokinase will be more extensive, providing strong support for the development of modern medicine and biotechnology.